Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023

CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India

The collaboration between CORONA and Ferring will cater to patients across India

Indoco receives EIR for its Plant I manufacturing facility in Goa

Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.

Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer

He has over two decades of leadership experience as an innovative strategic planner in finance diligence

Laurus Labs receives USFDA tentative approval for Dolutegravir 5mg and 10mg in HIV/AIDS treatment

It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment

Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil

Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder

IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr

Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22

RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr

Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23

Atul appoints Rangaswamy Iyer as Independent Director

The appointment is effective from May 01, 2023 for five years

PI Industries announces twin acquisitions into Pharma API & CDMO space